4.6 Article

Indocyanine Green: Photosensitizer or Chromophore? Still a Debate

Journal

CURRENT MEDICINAL CHEMISTRY
Volume 21, Issue 16, Pages 1871-1897

Publisher

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666131218095802

Keywords

Cytotoxic effects; fluorescence; hyperthermia; indocyanine Green (ICG); photodynamic therapy (PDT); selective photocoagulation; site-specific therapy

Ask authors/readers for more resources

Indocyanine green (ICG) is a water-soluble anionic tricarbocyanine dye developed during the Second World War that was first approved for clinical use in humans in 1956. The main features of ICG that make it suitable for bio-imaging applications are its near infrared absorption and its fluorescence. Although ICG is mainly used for its fluorescence emission properties, it has also been hypothesized that it can serve as a photosensitizer for photodynamic therapy applications, eliciting cytotoxic effects both in vitro and in vivo when used in combination with light at wavelengths in the region of 800-830 nm. Moreover, ICG can be used for hyperthermia of enhanced-photocoagulation of blood vessels treatment. In this paper we have gathered all the available data concerning the use of ICG for different treatments.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available